Showing 1 - 14 results of 14 for search '"Novo Nordisk"', query time: 0.04s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    From economics to health outcomes: Delving into the significance of reduced insulin prices by M Leuschner, M Strydom, V Steenkamp

    Published 2024-08-01
    “… The recent substantial price reductions in insulin therapy by major manufacturers prompt an examination of their impact on South Africa (SA)’s healthcare. While Eli Lilly, Novo Nordisk, and Sanofi cut prices on long-acting basal insulin, among others, significantly, these insulins are not on SA’s Essential Medicines List (EML) for primary healthcare. …”
    Get full text
    Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14